Evidence map›Paper›PMID 39061819›Full record

ArticleBioengineering (Basel, Switzerland)2024

Dual Attention-Based 3D U-Net Liver Segmentation Algorithm on CT Images.

Benyue Zhang, Shi Qiu, Ting Liang

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Benyue ZhangKey Laboratory of Spectral Imaging Technology CAS, Xi'an Institute of Optics and Precision Mechanics, Chinese Academy of Sciences, Xi'an 710119, China.
Shi QiuKey Laboratory of Spectral Imaging Technology CAS, Xi'an Institute of Optics and Precision Mechanics, Chinese Academy of Sciences, Xi'an 710119, China.ORCID 0000-0003-1548-6106
Ting LiangDepartment of Radiology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710119, China.

Funding

China Postdoctoral Science Foundation 2023M740760National Natural Science Foundation of China 82372035Shaanxi International Cooperation Key Project 2022KWZ-19
6 · The paper itself

Abstract

The liver is a vital organ in the human body, and CT images can intuitively display its morphology. Physicians rely on liver CT images to observe its anatomical structure and areas of pathology, providing evidence for clinical diagnosis and treatment planning. To assist physicians in making accurate judgments, artificial intelligence techniques are adopted. Addressing the limitations of existing methods in liver CT image segmentation, such as weak contextual analysis and semantic information loss, we propose a novel Dual Attention-Based 3D U-Net liver segmentation algorithm on CT images. The innovations of our approach are summarized as follows: (1) We improve the 3D U-Net network by introducing residual connections to better capture multi-scale information and alleviate semantic information loss. (2) We propose the DA-Block encoder structure to enhance feature extraction capability. (3) We introduce the CBAM module into skip connections to optimize feature transmission in the encoder, reducing semantic gaps and achieving accurate liver segmentation. To validate the effectiveness of the algorithm, experiments were conducted on the LiTS dataset. The results showed that the Dice coefficient and HD95 index for liver images were 92.56% and 28.09 mm, respectively, representing an improvement of 0.84% and a reduction of 2.45 mm compared to 3D Res-UNet.

Indexed as

3D U-NetCTdual attention mechanismsliver segmentationresidual connection

Identifiers

PMID39061819
PMCPMC11273630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.